← All patents

US20180066066A1

Her3 specific monoclonal antibodies for diagnostic and therapeutic use

University of Texas System

Abstract

Isolated or recombinant anti-HER3 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Ningyan Zhang
Priority date
March 14, 2013
Filing date
July 07, 2017
Publication date
March 08, 2018
Language
en
Metadata fetched
August 29, 2026 00:25